In cerebrospinal fluid ER chaperones ERp57 and calreticulin bind beta-amyloid (Q24302136)

2

0 references

Douglas A Olson

3

0 references

Sheftel J Cohen

4

0 references

Alan T Davis

5

0 references

W Gibson Wood

6

0 references

Robert A Kratzke

7

0 references

Jordan L Holtzman

Biochemical and Biophysical Research Communications

8

0 references

language of work or name

English

0 references

publication date

24 June 2005

0 references

published in

0 references

volume

332

0 references

issue

1

0 references

page(s)

50-7

0 references

cites work

Cerebrospinal fluid concentrations of soluble amyloid beta-protein and apolipoprotein E in patients with Alzheimer's disease: correlations with amyloid load in the brain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Exploring the etiology of Alzheimer disease using molecular genetics

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Evolving questions and paradigm shifts in endoplasmic-reticulum-associated degradation (ERAD).

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Reversal of beta-amyloid-induced retention deficit after exposure to training and state cues.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutions

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Soluble amyloid beta-protein in the cerebrospinal fluid from patients with Alzheimer's disease, vascular dementia and controls.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Amyloid beta binding proteins in vitro and in normal human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42).

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Two distinct stress signaling pathways converge upon the CHOP promoter during the mammalian unfolded protein response

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Amyloid beta protein 42(43) in cerebrospinal fluid of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

ER quality control: towards an understanding at the molecular level

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Protein disulfide-isomerase retains procollagen prolyl 4-hydroxylase structure in its native conformation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Evidence that casein kinase 2 phosphorylates hepatic microsomal calcium-binding proteins 1 and 2 but not 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A beta using physiological concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Translating cell biology into therapeutic advances in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

IRE1 couples endoplasmic reticulum load to secretory capacity by processing the XBP-1 mRNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Lipid binding to amyloid beta-peptide aggregates: preferential binding of cholesterol as compared with phosphatidylcholine and fatty acids

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

TROSY-NMR reveals interaction between ERp57 and the tip of the calreticulin P-domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Amyloid plaque core protein in Alzheimer disease and Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

The thiol-dependent reductase ERp57 interacts specifically with N-glycosylated integral membrane proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Complex, two-way traffic of molecules across the membrane of the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Regulation of internal ribosomal entry site-mediated translation by phosphorylation of the translation initiation factor eIF2alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Signaling the unfolded protein response from the endoplasmic reticulum.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

A new role for BiP: closing the aqueous translocon pore during protein integration into the ER membrane

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Progressive reduction of synaptophysin message in single neurons in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Progression of regional neuropathology in Alzheimer disease and normal elderly: findings from the Nun study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021

Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.BBRC.2005.04.090

7 January 2021